Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.510
-0.270 (-7.14%)
At close: Jul 15, 2025, 4:00 PM
3.530
+0.020 (0.57%)
After-hours: Jul 15, 2025, 4:00 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $37.21 million as of July 15, 2025. Its market cap has increased by 70.68% in one year.
Market Cap
37.21M
Enterprise Value
37.32M
1-Year Change
70.68%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $37.21M, a decrease of -31.23%. That is a compound annual growth rate of -6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 40.10M | 158.71% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |